股票市场 | 高德美股价大跌：FDA否决Relfydess
2026-07-01 08:06:46
据彭博社报道，瑞士皮肤科公司高德美集团(Galderma Group AG)称，美国食品药品监督管理局(FDA)否决其肉毒素Botox竞品Relfydess后，公司股价创逾一年最大跌幅。
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
